【中银国际升京东健康目标价至45港元 去年下半年利润胜预期】金十数据3月7日讯，中银国际发表报告指，京东健康(06618.HK)去年下半年总收入按年增长13%，小幅超出市场预期1%。虽然毛利率略低于市场预期叠加增加的经营费用，7.2%的经调整净利润率仍超出市场预期，主要由强劲的利息收入贡献。该行认为公司会在2025年谨慎加速在多种层面的主动投资力度，包括用户、医疗产品及服务、价格补贴、线下基础设施、全渠道发展以及AI层面的投入，目的为增强他们的核心供应链及履约能力以及用户心智。维持“买入”评级并将目标价由30港元升至45港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.